Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative

Giorgi Rossi, Paolo; Lebeau, Annette; Canelo Aybar, Carlos Gilberto; Saz-Parkinson, Zuleika; Quinn, Cecily; Langendam, Miranda W; Mcgarrigle, Helen; Warman, Sue; Rigau, David; Alonso-Coello, Pablo; Broeders, Mireille; Graewingholt, Axel; Posso, Margarita; Duffy, Stephen W; Schünemann, Holger

doi:10.1038/s41416-020-01247-z

visitant :: identificació

Pàgina inicial > Articles > Articles publicats > Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative > Citation

Giorgi Rossi, Paolo; Lebeau, Annette; Canelo Aybar, Carlos Gilberto; [et al.]. «Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative». British journal of cancer, Vol. 124 (february 2021), p. 1503-1512. DOI 10.1038/s41416-020-01247-z <https://ddd.uab.cat/record/240158> [Consulta: 8 abril 2025].

Dipòsit Digital de Documents de la UAB :: :: :: ::
Powered by v1.1.6
Mantingut per ::

Col·laborem